logo for DRTSW

DRTSW • NASDAQ

Alpha Tau Medical Ltd.

$0.61

+ Add to Watchlist

Stock Details

Market Cap 52,005,560
Day Change 0.12 (24.49%)
Volume 342,365
Avg Volume 14,810.952
Price Range 0.3251-0.6269

Overview

Country IL
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ

Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.

Financial Overview

52 Week High 0.505
52 Week High Date 2026-01-08
52 Week Low 0.13
52 Week Low Date 2025-04-09
10D Avg Trading Vol 0.04581
YTD Price Return Daily 44.1176
MTD Price Return Daily 44.1176